Chemoinformaics analysis of Phosphatidylcholine
Molecular Weight | 677.945 | nRot | 34 |
Heavy Atom Molecular Weight | 605.369 | nRig | 3 |
Exact Molecular Weight | 677.5 | nRing | 0 |
Solubility: LogS | -3.401 | nHRing | 0 |
Solubility: LogP | 7.406 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 118 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 46 | No. of Aromatic Carbocycles | 0 |
nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 72 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 36 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 8 | No. of Arom Bond | 0 |
nHA | 8 | APOL | 119.275 |
nHD | 0 | BPOL | 92.7669 |
QED | 0.029 |
Synth | 3.891 |
Natural Product Likeliness | 0.493 |
NR-PPAR-gamma | 0.436 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.033 |
Pgp-sub | 0.998 |
HIA | 0.908 |
CACO-2 | -5.274 |
MDCK | 0.0000156 |
BBB | 0.001 |
PPB | 0.97718 |
VDSS | 0.243 |
FU | 0.0248841 |
CYP1A2-inh | 0.031 |
CYP1A2-sub | 0.675 |
CYP2c19-inh | 0.386 |
CYP2c19-sub | 0.115 |
CYP2c9-inh | 0.172 |
CYP2c9-sub | 0.985 |
CYP2d6-inh | 0.072 |
CYP2d6-sub | 0.409 |
CYP3a4-inh | 0.715 |
CYP3a4-sub | 0.016 |
CL | 3.165 |
T12 | 0.762 |
hERG | 0.877 |
Ames | 0.116 |
ROA | 0.052 |
SkinSen | 0.95 |
Carcinogencity | 0.128 |
EI | 0.014 |
Respiratory | 0.512 |
NR-Aromatase | 0.668 |
Antiviral | No |
Prediction | 0.586859 |